No Data
No Data
Lantern Pharma Advances Cancer Therapies With RADR Platform and Global ADC Collaborations
Lantern Pharma Unveils Innovative AI-Powered Module to Improve the Precision, Cost and Timelines of Antibody-Drug Conjugate (ADC) Development for Cancer
Lantern Pharma Inc. (LTRN): AI-Driven Cancer Drug Development
Lantern Pharma Extends CSO's Employment Agreement
Is Lantern Pharma (NASDAQ:LTRN) In A Good Position To Invest In Growth?
12 Health Care Stocks Moving In Friday's Pre-Market Session
Unlock the Full List